Physician profile
Kimberly F Epling
NPI 1073616355
$6,423.79
in general payments reported to CMS, 2019-2025
17 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,009 · 2022: $2,497 · 2023: $710 · 2024: $987 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,917.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,871.29 | 2021-2025 | Dailies Total1, Clareon, Total30 |
| Bausch & Lomb Americas INC. | $1,067.38 | 2022-2025 | Infuse, Vyzulta, Xiidra |
| Sun Pharmaceutical Industries INC. | $486.10 | 2021-2025 | Cequa |
| Abbvie INC. | $325.33 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $304.73 | 2021 | |
| Eyevance Pharmaceuticals LLC | $273.83 | 2021 | |
| Dompe US, INC. | $210.88 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $201.44 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $152.06 | 2021-2025 | |
| Oyster Point Pharma, INC. | $142.22 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $101.94 | 2021-2023 | |
| Lombart Brothers, INC. | $99.99 | 2025 | Opd-III |
| Apellis Pharmaceuticals, INC. | $89.60 | 2024 | Syfovre |
| Allergan, INC. | $33.87 | 2021 | |
| Harrow Eye, LLC | $21.85 | 2024 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $21.52 | 2025 | |
| Lkc Technologies, INC. | $19.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Epling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.